Search results
John Craig Venter (born October 14, 1946) is an American biotechnologist and businessman. He is known for leading one of the first draft sequences of the human genome [1] [2] and assembled the first team to transfect a cell with a synthetic chromosome.
Craig Venter is the founder, chairman and CEO of the J. Craig Venter Institute in La Jolla, CA, United States. He will be giving the Mendel Lecture on Tuesday June 18 at 13.30 hrs. He talked to Mary Rice about his life and work.
Apr 28, 2020 · With his current series of breakthroughs in synthetic biology Craig Venter and his team are not so much creating life as joining life. Reverse-engineering evolution's long-refined tricks and...
In 2001, Craig Venter made headlines for sequencing the human genome. In 2003, he started mapping the ocean's biodiversity. And now he's created the first synthetic lifeforms -- microorganisms that can produce alternative fuels.
Sep 18, 2023 · Geneticist J. Craig Venter is best known for his role in sequencing the human genome and creating a ‘synthetic’ cell containing only genes that are necessary for life.
1st International SynBYSS Conference. Brining together the synthetic biology community with an explicit goal to invest in the young, diverse, and international future of synthetic biology. Join us December 9-12, 2024 at the University of Hawaiʻi at Mānoa.
Craig Venter and team make a historic announcement: they've created the first fully functioning, reproducing cell controlled by synthetic DNA. He explains how they did it and why the achievement marks the beginning of a new era for science.
May 2, 2007 · 270. 54K views 17 years ago. http://www.ted.com Genomics pioneer Craig Venter takes a break from his epic round-the-world expedition to talk about the millions of genes...
The J. Craig Venter Institute was founded in 1992 as The Institute for Genomic Research (TIGR). Through a series of consolidations occurring in 2004 and 2006 the institute was renamed the J. Craig Venter Institute.
Apr 30, 2024 · J. Craig Venter (born Oct. 14, 1946, Salt Lake City, Utah, U.S.) is an American geneticist, biochemist, and businessman who pioneered new techniques in genetics and genomics research and headed the private-sector enterprise, Celera Genomics, in the Human Genome Project (HGP).
